We are live on ! Find out more
MAM

Martingale Asset Management Portfolio holdings

AUM $3.99B
1-Year Est. Return 22.65%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+22.65%
3 Year Est. Return
+77.2%
5 Year Est. Return
+114.11%
10 Year Est. Return
+351.19%
AUM
$5.11B
AUM Growth
-$74.2M
Cap. Flow
-$242M
Cap. Flow %
-4.73%
Top 10 Hldgs %
12.59%
Holding
899
New
84
Increased
258
Reduced
378
Closed
104

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$32.1M
2
ADBE icon
Adobe
ADBE
+$30.7M
3
AAPL icon
Apple
AAPL
+$19.9M
4
MCD icon
McDonald's
MCD
+$19.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 20.61%
2 Technology 20.51%
3 Industrials 12.27%
4 Consumer Staples 12.15%
5 Financials 11.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPSC icon
776
Century Therapeutics
IPSC
$357M
$155K ﹤0.01%
49,151
FRBA icon
777
First Bank
FRBA
$471M
$140K ﹤0.01%
13,515
-8,625
-39% -$88K
MDRX
778
DELISTED
Veradigm Inc. Common Stock
MDRX
$140K ﹤0.01%
11,103
-41,234
-79% -$501K
RES icon
779
RPC Inc
RES
$1.28B
$136K ﹤0.01%
+18,967
New +$139K
QUAD icon
780
Quad
QUAD
$559M
$135K ﹤0.01%
35,867
VHI icon
781
Valhi
VHI
$380M
$134K ﹤0.01%
10,423
-806
-7% -$11.8K
PMVP icon
782
PMV Pharmaceuticals
PMVP
$59.7M
$133K ﹤0.01%
21,296
+20
+0.1% +$105
CBAN icon
783
Colony Bankcorp
CBAN
$465M
$127K ﹤0.01%
13,435
+20
+0.1% +$190
ALLO icon
784
Allogene Therapeutics
ALLO
$635M
$120K ﹤0.01%
24,226
-5
-0% -$27
EZPW icon
785
Ezcorp Inc
EZPW
$1.86B
$110K ﹤0.01%
+13,176
New +$114K
GPGI
786
GPGI Inc
GPGI
$4.28B
$108K ﹤0.01%
+18,924
New +$113K
ALEC icon
787
Alector
ALEC
$168M
$106K ﹤0.01%
+17,564
New +$123K
BLUE
788
DELISTED
bluebird bio
BLUE
$92K ﹤0.01%
1,398
MGNX icon
789
MacroGenics
MGNX
$243M
$87.1K ﹤0.01%
16,286
III icon
790
Information Services Group
III
$205M
$72.1K ﹤0.01%
+13,443
New +$69.6K
PGRE
791
DELISTED
Paramount Group
PGRE
$61.1K ﹤0.01%
13,800
-36,900
-73% -$164K
KYNB
792
Kyntra Bio
KYNB
$27.4M
$51.3K ﹤0.01%
760
-330
-30% -$136K
MRSN
793
DELISTED
Mersana Therapeutics
MRSN
$39.9K ﹤0.01%
485
+1
+0.2% +$146
ERAS icon
794
Erasca
ERAS
$6.19B
$30.4K ﹤0.01%
11,032
AAT
795
American Assets Trust
AAT
$1.47B
-72,044
Closed -$1.34M
ABG icon
796
Asbury Automotive
ABG
$4.24B
-1,189
Closed -$250K
APA icon
797
APA Corp
APA
$13B
-5,981
Closed -$216K
ARQT icon
798
Arcutis Biotherapeutics
ARQT
$3.24B
-46,904
Closed -$516K
ASH icon
799
Ashland
ASH
$3.29B
-12,437
Closed -$1.28M
ASO icon
800
Academy Sports + Outdoors
ASO
$3.01B
-12,799
Closed -$835K

Similar funds

Martingale Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Martingale Asset Management held 899 positions worth $5.11B, down 1.4% from $5.19B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Martingale Asset Management withdrew a net $242M in Q2 2023, closing 104 positions and reducing 378 holdings. Its most notable exit was Everest Group, an estimated $38.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

Against the trend, Martingale Asset Management opened a new position in McDonald's worth $20.4M.

  • Martingale Asset Management's largest Q2 2023 buy was McDonald's: 68,221 shares worth $20.4M.
  • Martingale Asset Management added most to Amazon in Q2 2023, an estimated $32.1M increase.
  • Martingale Asset Management's biggest Q2 2023 reduction was Broadcom, cutting an estimated $28.3M.
  • Martingale Asset Management fully exited Everest Group in Q2 2023, selling an estimated $38.2M.
  • Martingale Asset Management's ten largest holdings make up 13% of its $5.11B portfolio in Q2 2023.
  • Martingale Asset Management opened 84 new positions and closed 104 in Q2 2023.
  • Martingale Asset Management's portfolio value fell 1.4% quarter-over-quarter to $5.11B.

Based on Martingale Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.